"The Office of Information Management (OIM) resides within the Food and Drug Administration's FDA Office of Operations and is headed by the Chief Information Officer (CIO). The CIO reports to the agency's Chief Operating Officer. As head of OIM, the CIO is responsible for managing IT, creating a foundation to enhance the interoperability of systems, and managing more than 400 staff assigned to this office."@en . . "Office of Information Management"@en . "The Office of Information Management (OIM) resides within the Food and Drug Administration's FDA Office of Operations and is headed by the Chief Information Officer (CIO). The CIO reports to the agency's Chief Operating Officer. As head of OIM, the CIO is responsible for managing IT, creating a foundation to enhance the interoperability of systems, and managing more than 400 staff assigned to this office. The OIM was formed in 2008 as part of FDA's efforts to transition the management of IT from individual components (i.e., the various centers and Office of Regulatory Affairs) to a centralized office within the agency. The OIM is composed of five divisions: Business Partnership and Support, Systems Management, Infrastructure Operations, Technology, and Chief Information Officer Support. It is responsible for managing IT and other related services enterprisewide. This includes \n* developing the architecture, standards, policies, governance, best practices, and technology road map that support the business priorities of the agency, including managing IT infrastructure, telecommunications, security, business continuity and disaster recovery, strategic planning, capital planning and investment control, enterprise architecture, and applications development and management; \n* advising and providing assistance to the FDA Commissioner and senior management officials on IT resources and programs; \n* establishing and overseeing implementation of agency IT policy and governance, procedures, and processes for conformance with the Clinger-Cohen Act and the Paperwork Reduction Act; and \n* working with FDA business areas to develop and communicate the overall vision for the agency's IT program."@en . . . .